
http://info.afrindex.com
China-Africa Trade Information Service
Jiangsu Aishelun Medical Technology Group has raised its investment in Morocco to €20 million, up from the initial €5 million, to build a dedicated plant engaged in the production and distribution of medical devices, health tech equipment as well as associated products. This manufacturing facility will be established in Mohammed VI Tangier Tech City, a key industrial hub that is drawing an ever-growing number of Chinese and global high-tech enterprises.
It is anticipated that the project will strengthen Morocco’s leading status in advanced healthcare manufacturing across Africa, especially in the sectors of pharmaceuticals, medical devices and related health technologies. The Kingdom of Morocco capitalizes on its advantageous geostrategic location—as a pivotal gateway linking Europe and Africa—along with its signed Free Trade Agreements with the EU, the U.S. and other nations, modern infrastructural facilities such as the Tanger Med Port, a highly skilled labor force, and government incentive policies, all to attract foreign investment and foster local manufacturing capacity.
Morocco’s healthcare industry is reaping the rewards of forward-looking reform measures, which include the universalization of healthcare coverage and the expansion of public funding for the modernization of medical infrastructure. The country’s core objective is to cut down on imports of high-cost medical devices and enhance local manufacturing, thereby positioning Morocco as a regional center for generic medicines, biosimilars, vaccines and medical apparatus.